Intuitive Surgical reported $11.0B of revenue over the trailing twelve months, +21% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $11.0B (to Q2 2026). Net income: $3.14B, trailing twelve months to Q2 2026. Free cash flow: $3.22B, trailing twelve months to Q2 2026. Operating margin: 31%, trailing twelve months to Q2 2026.

ISRGIntuitive Surgical

Healthcare

$423.91-2.7% 1Y

$423.91

$332.4252 weeks$592.85

ISRG as reported

Intuitive Surgical reported $11.0B of revenue over the trailing twelve months, +21% on the year before. 10 reported series are charted on this page, each one as filed.

$11.0B

Revenue, trailing twelve months · to Q2 2026 · +21% against the twelve months before

Net income: $3.14B
Net income · +20% year on year · trailing twelve months to Q2 2026
Free cash flow: $3.22B
Free cash flow · +62% year on year · trailing twelve months to Q2 2026
Operating margin: 31%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ISRG, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$11.0B	+21%	Q2 2026
Net income	$3.14B	+20%	Q2 2026
EPS	$8.72	+21%	Q2 2026
Gross margin	67%	n/a	Q2 2026
Operating margin	31%	n/a	Q2 2026
Net margin	28%	n/a	Q2 2026
ROE	17%	n/a	Q2 2026
ROA	15%	n/a	Q2 2026
Free cash flow	$3.22B	+62%	Q2 2026
P/E	48.6	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.